» Articles » PMID: 29925158

[Risk Factors and Preoperative Evaluation of Lymph Nodes Posterior to Right Recurrent Laryngeal Nerve Metastasis in Thyroid Papillary Carcinoma]

Overview
Date 2018 Jun 21
PMID 29925158
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the risk factors and preoperative evaluation of lymph nodes posterior to right recurrent laryngeal nerve (LN-prRLN) metastasis in papillary thyroid carcinoma (PTC). Clinical data of 301 patients with right or double lobes who underwent surgery between August 2015 and October 2016 in the Department of Thyroid Surgery, the First Hospital of China Medical University, were retrospectively analyzed. The relationships between LN-prRLN metastasis and clinical pathology data and other factors were analyzed. The enhanced CT difference of LN-prRLN was analyzed by receiver operating characteristic (ROC) curves. LN-prRLN metastasis was detected in 46 patients. Univariate analysis showed that age, tumor diameter, Delphian lymph node metastasis, lymph nodes anterior to right recurrent laryngeal nerve (LN-arRLN) metastasis number, and the number of lateral compartment lymph node metastases were significantly associated with LN-prRLN metastasis (all <0.05). Multivariate logistic regression analysis showed that LN-arRLN metastasis and right lateral compartment lymph node metastasis were independent risk factors for LN-prRLN metastasis (both <0.05). The area under the ROC curve for contrast-enhanced thyroid CT was 0.948 (<0.001), the cut-off value was 72 Hu, and the best sensitivity and specificity were 90.5% and 94.1%, respectively, with a Youden index of 0.846. LN-prRLN dissection is recommended when there exists LN-arRLN metastasis or right lateral compartment lymph node metastasis in patients with PTC, especially when preoperative contrast-enhanced CT shows LN-prRLN and contrast-enhanced CT is ≥72 Hu.

Citing Articles

A Novel Scoring System for Predicting the Metastases of Posterior Right Recurrent Laryngeal Nerve Lymph Node Involvement in Patients With Papillary Thyroid Carcinoma by Preoperative Ultrasound.

Lu K, Zhang Y, Da J, Zhou T, Zhao L, Peng Y Front Endocrinol (Lausanne). 2021; 12:738138.

PMID: 34531829 PMC: 8439577. DOI: 10.3389/fendo.2021.738138.


Unnecessity of Routine Dissection of Right Central Lymph Nodes in cN0 Papillary Thyroid Carcinoma Located at the Left Thyroid Lobe.

Zhang S, Zhang R, Wang C, Gong W, Zheng C, Fang Q Front Oncol. 2021; 11:685708.

PMID: 34277432 PMC: 8281883. DOI: 10.3389/fonc.2021.685708.


A meta-analysis of risk factors for lymph node posterior to the right recurrent laryngeal nerve metastasis in papillary thyroid carcinoma.

Zhou T, Wu F, Zhao L, Jiang K, Luo D Gland Surg. 2021; 10(6):1841-1851.

PMID: 34268069 PMC: 8258886. DOI: 10.21037/gs-21-177.


[Analysis of the factors for the lymph node metastasis in rⅥb region of thyroid micropapillary carcinoma and the application value of intraoperative nano-carbon].

Sun Z, Zhao Z, Jiang H Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020; 34(4):355-359.

PMID: 32842233 PMC: 10127759. DOI: 10.13201/j.issn.2096-7993.2020.04.017.